Advertisement
Advertisement

Archive

2012: 108/6 (Dec) pp. 1009–1248

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Theme Issue
Scoring in thrombotic cardiovascular disease


32 articles
1.
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm
An Executive Summary of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis

G. Y. H. Lip (1), P. Piotrponikowski (2), F. Andreotti (3), S. D. Anker (4), G. Filippatos (5), S. Homma (6), J. Morais (7), P. Pullicino (8, 9), L. H. Rasmussen (10), F. Marín (11), D. A. Lane (1)

(1) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, BirminghamUK; (2) Departement of Heart Disease, Military Hospital, Medical University, Wroclaw, Poland; (3) Department of Cardiovascular Sciences, Catholic University Hospital, Rome, Italy; (4) Departmentof Cardiology,Campus Virchow-Klinikum,Charité Universitätsmedizin Berlin, Germany; (5) Department of Cardiology, Heart Failure Unit, Athens University Hospital Attikon, Athens, Greece; (6) Cardiology Division, Columbia University Medical Center, New York, NY, USA; (7) Cardiology Division. Santo Andre´s Hospital, Leiria, Portugal; (8) KentHealth, University of Kent, Kent, UK; (9) Department of Neurology and Neuroscience, New Jersey Medical School, Newark, New Jersey, USA; (10) Thrombosis Research Unit, Aalborg University Hospital, Faculty of Medicine, Aalborg University, Aalborg, Denmark; (11) Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain

Thromb Haemost 2012 108 6: 1009-1022

https://doi.org/10.1160/TH12-08-0578

[Summary] [Free PDF] [Export citation]
2.

T&H Insight on Kapusta et al.

J. Wojta (1)

(1) Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria

Thromb Haemost 2012 108 6: 1023-1023

https://doi.org/10.1160/TH12-10-0783

[Summary] [Free PDF] [Export citation]
3.

See also articles by Cattaneo, Faioni and Schrör

V. L. Serebruany (1)

(1) HeartDrug™ Research Laboratories, Johns Hopkins University, Towson, Maryland, Maryland, USA

Thromb Haemost 2012 108 6: 1024-1027

https://doi.org/10.1160/TH12-03-0180

[Summary] [Free PDF] [Export citation]
4.
'Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel' – a hypothesis that remains unproven
Editorial on Serebruany: ‘Viewpoint: Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel’ (Thromb Haemost 2012; 108.6)

See also articles by Cattaneo, Faioni and Serebruany

K. Schrör (1)

(1) Institut für Pharmakologie und Klinische Pharmakologie, UniversitätsKlinikum, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany

Thromb Haemost 2012 108 6: 1028-1030

https://doi.org/10.1160/TH12-07-0513

[Summary] [Free PDF] [Export citation]
5.

See also articles by Schrör and Serebruany

M. Cattaneo (1), E. M. Faioni (1)

(1) Medicina 3, Ospedale San Paolo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy

Thromb Haemost 2012 108 6: 1031-1036

https://doi.org/10.1160/TH12-08-0547

[Summary] [Free PDF] [Export citation]
6.

D. Bonderman (1), P. Wexberg (2), H. Heinzl (3), I. M. Lang (1)

(1) Department of Cardiology, Medical University of Vienna, Austria; (2) Second Medical Department, Krankenanstalt Rudolfstiftung, Vienna, Austria; (3) Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Austria

Thromb Haemost 2012 108 6: 1037-1041

https://doi.org/10.1160/TH12-04-0239

[Summary] [Free PDF] [Export citation]
7.

J. Thaler (1, 2), C. Ay (1, 2), I. Pabinger (1, 2)

(1) Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria; (2) Comprehensive Cancer Center Vienna, Medical University of Vienna – Vienna General Hospital, Vienna, Austria

Thromb Haemost 2012 108 6: 1042-1048

https://doi.org/10.1160/TH12-04-0241

[Summary] [Free PDF] [Export citation]
8.

R. L. Benza (1), M. Gomberg-Maitland (2), A. E. Frost (3), R. P. Frantz (4), M. Humbert (5), M. D. McGoon (4)

(1) Allegheny General Hospital, Pittsburgh, Pennsylvania, USA; (2) University of Chicago Medical Center, Chicago, Illinois, USA; (3) Baylor College of Medicine, Houston, Texas, USA; (4) Mayo Clinic, Rochester, Minnesota, USA; (5) Université Paris-Sud, Inserm U999, Hôpital Antoine-Béclère, AP-HP, Clamart, France

Thromb Haemost 2012 108 6: 1049-1060

https://doi.org/10.1160/TH11-11-0821

[Summary] [Free PDF] [Export citation]
9.

P. A. Kyrle (1, 2), S. Eichinger (1, 2)

(1) Department of Medicine I, Medical University of Vienna, Vienna, Austria; (2) Karl Landsteiner Institute of Thrombosis Research, Vienna, Austria

Thromb Haemost 2012 108 6: 1061-1064

https://doi.org/10.1160/TH12-05-0353

[Summary] [Free PDF] [Export citation]
10.

B. Metzler (1), B. Winkler (2)

(1) Department of Internal Medicine III / Cardiology, Innsbruck Medical University, Austria; (2) Department of Cardiology, King´s College, London, UK

Thromb Haemost 2012 108 6: 1065-1071

https://doi.org/10.1160/TH11-06-0399

[Summary] [Free PDF] [Export citation]
11.

A. C. Spyropoulos (1), T. McGinn (2), A. Khorana (3)

(1) Division of Hematology and Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA; (2) North Shore/LIJ Health System, Department of Medicine, New York, New York, USA; (3) James P. Wilmot Cancer Center and Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA

Thromb Haemost 2012 108 6: 1072-1076

https://doi.org/10.1160/TH12-07-0508

[Summary] [Free PDF] [Export citation]
12.

Online Supplementary Material

D. J. F. Stuijver (1, 2), B. van Zaane (1, 2), E. Romualdi (3), D. P. M. Brandjes (1, 2), V. E. A. Gerdes (1, 2), A. Squizzato (3)

(1) Department of Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands; (2) Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands; (3) Department of Clinical Medicine, University of Insubria, Varese, Italy

Thromb Haemost 2012 108 6: 1077-1088

https://doi.org/10.1160/TH12-07-0496

[Summary] [Free PDF] [Export citation]
13.

R. A. Fraga-Silva (1), D. G. Da Silva (1), F. Montecucco (2, 3), F. Mach (2), N. Stergiopulos (1), R. F. da Silva (1, 4), R. A. S. Santos (4)

(1) Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; (2) Division of Cardiology, Geneva University Hospitals, Faculty of Medicine, Foundation for Medical Researches, Geneva, Switzerland; (3) First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy; (4) National Institute of Science and Technology in Nanobiopharmaceutics, Department of Physiology and Biophysics, Biological Science Institute, Federal University of Minas Gerais, Brazil

Thromb Haemost 2012 108 6: 1089-1096

https://doi.org/10.1160/TH12-06-0396

[Summary] [Free PDF] [Export citation]
14.

J. D. Grant (1), S. M. Stevens (2, 3), S. C. Woller (2, 3), E. W. Lee (4), S. T. Kee (4), D. M. Liu (5), D. G. Lohan (6), C. G. Elliott (2, 3)

(1) Division of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA; (2) Department of Medicine, Intermountain Medical Center, Murray, Utah, USA; (3) Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA; (4) Division of Interventional Radiology, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA; (5) Department of Radiology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; (6) Department of Radiology, Galway University Hospitals, Galway, Ireland

Thromb Haemost 2012 108 6: 1097-1108

https://doi.org/10.1160/TH12-05-0352

[Summary] [Free PDF] [Export citation]
15.

P. Ferroni (1), S. Riondino (1), N. Vazzana (2), N. Santoro (2), F. Guadagni (1), G. Davì (2)

(1) Department of of Advanced Biotechnologies and Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy; (2) Internal Medicine and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy

Thromb Haemost 2012 108 6: 1109-1123

https://doi.org/10.1160/TH12-08-0550

[Summary] [Free PDF] [Export citation]
16.

See also Editorial Focus by Tung, Boyle

L. Feng (1), Y. Li (1), J. Li (1), B. Yu (1)

(1) Department of Cardiology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, P. R. China

Thromb Haemost 2012 108 6: 1124-1131

https://doi.org/10.1160/TH12-07-0498

[Summary] [Free PDF] [Export citation]
17.

Q. Xu (1), B. Xu (1), Y. Zhang (1), J. Yang (1), L. Gao (1), Y. Zhang (1), H. Wang (1), C. Lu (1), Y. Zhao (1), T. Yin (1)

(1) Institute of Geriatric Cardiology, General Hospital of People’s Liberation Army, Beijing, China

Thromb Haemost 2012 108 6: 1132-1140

https://doi.org/10.1160/TH12-05-0362

[Summary] [PDF] [Pay per view] [Export citation]
18.

Online Supplementary Material

H. Wang (1, 2), I. Vinnikov (3), K. Shahzad (1, 4), F. Bock (1, 5), S. Ranjan (1), J. Wolter (1), M. Kashif (5), J. Oh (6), A. Bierhaus (5), P. Nawroth (5), M. Kirschfink (7), E. M. Conway (8), T. Madhusudhan (1), B. Isermann (1)

(1) Department of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; (2) Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; (3) Molecular Biology of the Cell I, German Cancer Research Center, Heidelberg, Germany; (4) University of Health Sciences, Khayaban-e-Jamia Punjab, Lahore, Pakistan; (5) Internal Medicine I and Clinical Chemistry, University of Heidelberg, INF 410, Heidelberg, Germany; (6) Department of Paediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; (7) Institute of Immunology, University of Heidelberg, INF 305, Heidelberg, Germany; (8) UBC Centre for Blood Research, Faculty of Medicine, Division of Haematology, Life Sciences Centre, Vancouver, British Columbia, Canada

Thromb Haemost 2012 108 6: 1141-1153

https://doi.org/10.1160/TH12-07-0460

[Summary] [PDF] [Pay per view] [Export citation]
19.

S. H. Qureshi (1), L. Yang (1), A. R. Rezaie (1)

(1) Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Thromb Haemost 2012 108 6: 1154-1164

https://doi.org/10.1160/TH12-06-0436

[Summary] [PDF] [Pay per view] [Export citation]
20.

A. Bergrem (1, 2, 3), A. E. A. Dahm (1, 2), A. F. Jacobsen (4), L. Sandvik (5), P. M. Sandset (1, 2, 3)

(1) Departement of Haematology, Oslo University Hospital, Oslo, Norway; (2) Research Institute of Internal Medicine, Oslo, Norway; (3) University of Oslo, Institute of Clinical Medicine, Oslo, Norway; (4) Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway; (5) Clinical Research, Oslo University Hospital, Oslo, Norway

Thromb Haemost 2012 108 6: 1165-1171

https://doi.org/10.1160/TH12-05-0350

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-32